Author

Jiayao Fan

Second Affiliated Hospital of Zhejiang University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:database / resource· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Dan ZhouiD· 2 shared Ai‐Min BaoiD· 1 shared Changzheng YuaniD· 1 shared Chao CheniD· 1 shared Chao MaiD· 1 shared Chunfeng He· 1 shared Chunxiao ChengiD· 1 shared Dandan ZhangiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Dan ZhouORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The China Brain Multi-omics Atlas Project (CBMAP)

Dan Zhou, Yuan Zhou, Zeyu Sun, Feiyang Ji, Dandan Zhang, Quan Wang, Yijun Ruan, Yongcheng Wang, Yimin Zhu, Xiaohui Sun, Mulin Jun Li, Changzheng Yuan, Kefu Liu, Lingyun Sun, Wenli Zhai, , Jing Zhang

The China Brain Multi-omics Atlas Project (CBMAP) creates a comprehensive molecular reference map of over 1,000 human brains to address underrepresentation in East Asian populations and advance research on aging and neuropsychiatric disorders.

Molecular Psychiatry · Sep 15, 2025Peer-reviewedNeuroscience

Integrating population-level and cell-based signatures for drug repositioning

Chunfeng He, Yue Xu, Yuan Zhou, Jiayao Fan, Chunxiao Cheng, Ran Meng, Lang Wu, Ruiyuan Pan, Ravi V. Shah, Eric R. Gamazon, Dan Zhou

This paper introduces TReD, a framework integrating population-level disease signatures and cell-based drug responses to identify potential therapeutics for COVID-19 and T2D.

Bioinformatics · Sep 9, 2025Peer-reviewedBioinformatics